Streetbeat News

Equity Actions

COIN

QQQ

SPY

VOO

The article emphasizes the benefits of long-term investing, taking inspiration from Warren Buffett's approach. It argues against the pessimistic predictions of a recession and market lows, highlighting that markets have historically trended upwards. The article suggests buying and holding core stocks/ETFs like SPY, QQQ, and VOO, which are near all-time highs, regardless of market conditions. It also mentions the success of buying speculative stocks like COIN over time, which has seen a significant increase since 2022's drop.

Portfolio Pulse from Thrash Capital

January 03, 2024 | 4:32 pm

AAPL

F

KRUZ

META

MSFT

NANC

NVDA

SPY

A report by Unusual Whales revealed that 32 members of Congress outperformed the S&P 500 in 2023, with top sectors traded including Technology, Energy, Healthcare, Consumer Defensive, and Financial Services. The report also highlighted top stocks bought and sold by Congress members, with ETFs NANC and KRUZ allowing investors to follow their trades. Top stocks bought included AAPL, MSFT, and F, while top stocks sold included MSFT, META, and NVDA.

Portfolio Pulse from Chris Katje

January 03, 2024 | 4:29 pm

ACR

DHC

HPP

MAC

OPI

PKST

RMR

December saw a significant rally in REITs, attributed to the Federal Reserve's pause on interest rate hikes and anticipated rate cuts in 2024. Office REITs and mortgage REITs (mREITs) performed exceptionally well, with some experiencing over 20% gains. Hudson Pacific Properties (HPP) led the surge with a 53.66% return, followed by Macerich Co. (MAC), Peakstone Realty Trust (PKST), Acres Commercial Realty Corp. (ACR), and Office Properties Income Trust (OPI). Analyst upgrades and internal corporate actions, such as share repurchase programs and management changes, contributed to the positive performance of these REITs.

Portfolio Pulse from Ethan Roberts

January 03, 2024 | 4:05 pm

SHOP

Benzinga's options scanner detected 23 unusual options trades for Shopify (NYSE:SHOP), indicating a predominantly bullish sentiment among big-money investors, with 69% bullish and 30% bearish. The trades suggest a target price range of $35.0 to $81.0 for the next three months. The volume and open interest for these options trades are also notably high. Currently, SHOP's stock price is down by -1.82%, with a neutral RSI and the next earnings report due in 42 days.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:01 pm

BJRI

BJ's Restaurants (NASDAQ:BJRI) received mixed analyst ratings in the latest quarter, with 10 analysts providing various stances. The average 12-month price target is $31.6, with a high of $41.00 and a low of $23.00, marking a slight decrease from the previous average of $32.17. Analysts from firms like Barclays, Piper Sandler, Stephens & Co., Wedbush, Benchmark, and Citigroup have made adjustments to their ratings and price targets. BJ's Restaurants has shown a revenue growth of 2.34% as of September 30, 2023, but lags behind industry peers. The company has a net margin of -1.19%, an ROE of -1.05%, an ROA of -0.37%, and a debt-to-equity ratio of 1.26.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:00 pm

MXL

MaxLinear (NASDAQ:MXL) has been evaluated by 10 analysts over the last three months, with a mix of bullish to bearish sentiments. The average 12-month price target for MXL is now $26.5, down from the previous $36.11, indicating a 26.61% decline. Several analysts from firms like Wells Fargo, Stifel, Benchmark, Susquehanna, Roth MKM, and Deutsche Bank have lowered their price targets for MXL. MaxLinear faces revenue challenges with a -52.57% decline over 3 months and has a net margin of -29.39%, but a relatively healthy debt-to-equity ratio of 0.23.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:00 pm

CDW

CDW Corp (NASDAQ:CDW) is evaluated against competitors in the Electronic Equipment, Instruments & Components industry. CDW trades at a premium with a P/E of 27.55, P/B of 16.33, and P/S of 1.38, all above industry averages. The company's ROE at 18.43% and higher EBITDA and gross profit indicate strong profitability, despite a revenue decline of -9.45%. CDW's high debt-to-equity ratio of 3.24 suggests increased financial risk.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:00 pm

UTZ

Utz Brands (NYSE:UTZ) received mixed analyst ratings in the latest quarter, with 10 analysts offering a range of opinions. The average 12-month price target is now $16.6, down from $18.00, indicating a 7.78% decrease. Analysts from firms including Needham, Mizuho, Piper Sandler, RBC Capital, Goldman Sachs, Truist Securities, Jefferies, Stephens & Co., B of A Securities, and Barclays have updated their ratings and price targets, reflecting their views on the company's market dynamics and performance. Utz Brands, a snack food manufacturer, has seen a 2.49% revenue growth rate over 3 months but faces challenges with a below-average ROE of 2.29%, ROA of 0.57%, and a high debt-to-equity ratio of 1.42.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:00 pm

BNTX

A comparative study evaluates BioNTech (NASDAQ:BNTX) against its biotechnology industry competitors, analyzing financial metrics and market position. BioNTech's low P/E, P/B, and P/S ratios suggest undervaluation, but its ROE, EBITDA, gross profit, and revenue growth are below industry averages, indicating potential financial weaknesses. The company's low debt-to-equity ratio is favorable, suggesting a strong financial position with less reliance on debt.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:00 pm

SRE

Sempra (NYSE:SRE) received mixed analyst ratings over the last quarter, with 1 bullish, 2 somewhat bullish, and 3 indifferent. The average 12-month price target is $78.25, slightly up from the previous $78.20. Analysts from Ladenburg Thalmann, JP Morgan, Morgan Stanley, and Barclays have adjusted their ratings and price targets, reflecting their views on the company's performance and market conditions. Sempra, a large utility company, has seen a revenue decline of -7.82% but maintains strong financial health with a high net margin of 21.63% and above-average ROE and ROA. Its debt-to-equity ratio is conservative at 1.12.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 4:00 pm